Product Overview
Sitagliptin Phosphate Monohydrate is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor.
Sitagliptin Phosphate Monohydrate helps control blood sugar in people with type 2 diabetes.
It does this by increasing active incretin hormone levels.
Sitagliptin works by inhibiting DPP-4, the enzyme responsible for breaking down incretin hormones like GLP-1, thereby increasing insulin release and reducing glucagon levels
Therapeutic Applications
-
Useful in oral dosage forms
-
Sitagliptin Phosphate Monohydrate (CAS 654671-77-9) is an oral antidiabetic agent prescribed to improve glycemic control in adults with T2DM.
-
Used together with other antidiabetic agents.
-
Sitagliptin is generally considered weight-neutral.
-
Sitagliptin is used with accustomed doses in patients with mild to moderate renal impairment.
Specification Parameters
-
Name of the chemical: Canagliflozin
-
White to off-white crystalline powder.
-
Freely soluble in water and methanol.
-
Residual solvents are in accordance with ICH guidelines.
Packaging & Storage
-
Packages available are 1 kg, 5 kg, and 10 kg HDPE drums.
-
They come in double-layer polyethylene bags.
-
Custom-based packaging is available on request.
Why Choose Us
Actiza Industry supply Sitagliptin Phosphate Monohydrate with high purity and regulatory documentation support.
Each of our batches undergoes definite testing to meet international pharmacopoeia standards.
Customised bulk packaging is also available with full regulatory documentation.
Our wide logistic support delivers Sitagliptin Phosphate Monohydrate across different countries.
Our team supports you in each of your queries and other product-related information.
